Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 07, 2021

SELL
$0.86 - $1.21 $36,019 - $50,678
-41,883 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$1.04 - $1.69 $3,909 - $6,352
3,759 Added 9.86%
41,883 $50,000
Q1 2021

May 04, 2021

SELL
$1.32 - $3.79 $21,494 - $61,716
-16,284 Reduced 29.93%
38,124 $62,000
Q4 2020

Feb 02, 2021

BUY
$1.06 - $1.51 $57,672 - $82,156
54,408 New
54,408 $67,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $5.99M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.